Ann Clin Microbiol.  2024 Sep;27(3):197-204. 10.5145/ACM.2024.27.3.1.

Clinical performance of the ImmuneMed Dengue NS1 Ag Rapid I test for the diagnosis of dengue fever: a diagnostic accuracy study

• Namirimu T
• Kim S

• KMID: 2559811
• DOI: http://doi.org/10.5145/ACM.2024.27.3.1

Abstract

Background
Dengue virus (DENV) is transmitted by mosquitoes and is becoming a global threat owing to an increase in the number of cases and mortality, especially in low- and middle-income tropical countries. Rapid and easy-to-use diagnostic tests are required to differentiate dengue fever from other febrile illnesses.
Methods
We evaluated the clinical performance of the ImmuneMed Dengue NS1 Ag Rapid I test (ImmuneMed, Inc.) using positive and negative sera collected from patients with confirmed DENV infection and healthy individuals, respectively. The AccuPower® ZIKV (DENV, CHIKV) multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) assay (Bioneer) was used as the reference standard to confirm DENV infection.
Results
One hundred DENV-positive and 161 DENV-negative samples were evaluated. Overall, the sensitivity and specificity were 100% (95% confidence interval [CI], 96%–100%) and 100% (95% CI, 98%–100%), respectively. The sensitivity and specificity were 100% for both DENV-1 and DENV- 2. The sensitivity was the same (100%) for sera collected ＜ 3 days and ≥ 3 days from symptom onset. The performance of the ImmuneMed Dengue NS1 Ag Rapid I and realtime RT-PCR tests showed strong overall agreement.
Conclusion
The ImmuneMed Dengue NS1 Ag Rapid I test was highly specific for DENV and as sensitive as RT-PCR. These findings suggest that the ImmuneMed Dengue NS1 Ag Rapid I test may be a useful point-of-care test for dengue fever.

Keyword

Dengue; Dengue virus; Reverse transcriptase polymerase chain reaction; Pointof-care systems; Routine diagnostic tests

Reference

1. Holmes EC. Molecular epidemiology and evolution of emerging infectious diseases. Br Med Bull 1998;54:533-43.

2. Mustafa M, Rasotgi V, Jain CS, Gupta V. Discovery of fifth serotype of dengue virus (DENV5): a new public health dilemma in dengue control. Med J Armed Forces India 2015;71:67-70.

3. Normile D. Surprising new dengue virus throws a spanner in disease control efforts. Science 2013;342:415.

4. Wahala WM and De Silva AM. The human antibody response to dengue virus infection. Viruses 2011;3:2374-95.

5. Guzmán MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol 2000;152:793-9.

6. Winter PE, Nantapanich S, Nisalak A, Udomsakdi S, Dewey RW, Russell PK. Recurrence of epidemic dengue hemorrhagic fever in an insular setting. Am J Trop Med Hyg 1969;18:573-9.

7. Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, et al. Antibodydependent enhancement of severe dengue disease in humans. Science 2017;358:929-32.

8. Guzman MG and Harris E. Dengue. Lancet 2015;385:453-65.

9. Sangkawibha N, Rojanasuphot S, Ahandrik S, Viriyapongse S, Jatanasen S, Salitul V, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand: I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69.

10. WHO. Dengue guidelines for diagnosis, treatment, prevention and control: new edition. Geneva: World Health Organization; 2009.

11. Balmaseda A, Hammond SN, Pérez L, Tellez Y, Saborío SI, Mercado JC, et al. Serotypespecific differences in clinical manifestations of dengue. Am J Trop Med Hyg 2006;74:449-56.

12. Vicente CR, Herbinger KH, Fröschl G, Romano CM, de Souza Areias Cabidelle A, Cerutti Jr. C. Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vitória, Brazil. BMC Infect Dis 2016;16:1-7.

13. Nisalak A, Endy TP, Nimmannitya S, Kalayanarooj S, Thisayakorn U, Scott RM, et al. Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg 2003;68:191.

14. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000;181:2-9.

15. Narvaez F, Montenegro C, Juarez JG, Zambrana JV, Gonzalez K, Arguello S, et al. Dengue severity by serotype in 19 years of pediatric clinical studies in Nicaragua. medRxiv [Preprint]. 2024 [cited 2024 June 30]. Available from: https://www.medrxiv.org/ content/10.1101/2024.02.11.24302393v2.

16. Perera R and Kuhn RJ. Structural proteomics of dengue virus. Curr Opin Microbiol 2008;11:369-77.

17. Lindenbach BD and Rice CM. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 1997;71:9608-17.

18. Mackenzie JM, Jones MK, Young PR. Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 1996;220:232-40.

19. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis 2002;186:1165-8.

20. Duyen HT, Ngoc TV, Ha DT, Hang VT, Kieu NT, Young PR, et al. Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status. J Infect Dis 2011;203:1292-300.

21. Young PR, Hilditch PA, Bletchly C, Halloran W. An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol 2000;38:1053-7.

22. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M. Enzyme-linked immunosorbent assay specific to dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002;40:376-81.

23. Pal S, Dauner AL, Mitra I, Forshey BM, Garcia P, Morrison AC, et al. Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples. PLoS One 2014;9:e113411.

24. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992;30:545-51.

25. Wiwanitkit V. Dengue fever: diagnosis and treatment. Expert Rev Anti Infect Ther 2010;8:8415.

26. Yow KS, Aik J, Tan EYM, Ng LC, Lai YL. Rapid diagnostic tests for the detection of recent dengue infections: an evaluation of six kits on clinical specimens. PLoS One 2021;16:e0249602.

27. Blacksell SD, Jarman RG, Bailey MS, Tanganuchitcharnchai A, Jenjaroen K, Gibbons RV, et al. Evaluation of six commercial point-of-care tests for diagnosis of acute dengue infections: the need for combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of accuracy. Clin Vaccine Immunol 2011;18:2095-101.

28. Osorio L, Ramirez M, Bonelo A, Villar LA, Parra B. Comparison of the diagnostic accuracy of commercial NS1-based diagnostic tests for early dengue infection. Virol J 2010;7:361.

29. Liu LT, Chen CH, Tsai CY, Lin PC, Hsu MC, Huang BY, et al. Evaluation of rapid diagnostic tests to detect dengue virus infections in Taiwan. PLoS One 2020;15:e0239710.

30. Suputtamongkol Y, Avirutnan P, Wongsawat E, Kim YW. Performance of two commercial dengue NS1 rapid tests for the diagnosis of adult patients with dengue infection. Siriraj Med J 2020;72:74-8.

31. Mata VE, de Andrade CAF, Passos SRL, Hökerberg YHM, Fukuoka LVB, da Silva SA. Rapid immunochromatographic tests for the diagnosis of dengue: a systematic review and metaanalysis. Cad Saude Publica 2020;36:e00225618.

32. Lindenbach BD and Rice CM. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J Virol 1997;71:9608-17.